GABRR1 and GABRR2 |
gamma-aminobutyric acid (GABA) A receptor, rho 1 |
gamma-aminobutyric acid (GABA) A receptor, rho 2 |
- GABA receptor activation
- GABA A (rho) receptor activation
- Ion channel transport
- Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
- Ligand-gated ion channel transport
- Transmission across Chemical Synapses
|
- GABA receptor activation
- GABA A (rho) receptor activation
- Ion channel transport
- Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
- Ligand-gated ion channel transport
- Transmission across Chemical Synapses
|
- Lorazepam
- Temazepam
- Clobazam
- Alprazolam
- Picrotoxin
- Chlordiazepoxide
- Adinazolam
- Clorazepate
- Midazolam
- Flurazepam
- Halazepam
- Diazepam
- Oxazepam
- Triazolam
- Clonazepam
- Estazolam
- Bromazepam
- Clotiazepam
- Fludiazepam
- Prazepam
- Quazepam
- Cinolazepam
- Nitrazepam
|
|
|
|
GABRR1 and MAP1B |
gamma-aminobutyric acid (GABA) A receptor, rho 1 |
microtubule-associated protein 1B |
- GABA receptor activation
- GABA A (rho) receptor activation
- Ion channel transport
- Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
- Ligand-gated ion channel transport
- Transmission across Chemical Synapses
|
|
- Lorazepam
- Temazepam
- Clobazam
- Alprazolam
- Picrotoxin
- Chlordiazepoxide
- Adinazolam
- Clorazepate
- Midazolam
- Flurazepam
- Halazepam
- Diazepam
- Oxazepam
- Triazolam
- Clonazepam
- Estazolam
- Bromazepam
- Clotiazepam
- Fludiazepam
- Prazepam
- Quazepam
- Cinolazepam
- Nitrazepam
|
|
|
|
GABRR1 and SLC6A9 |
gamma-aminobutyric acid (GABA) A receptor, rho 1 |
solute carrier family 6 (neurotransmitter transporter, glycine), member 9 |
- GABA receptor activation
- GABA A (rho) receptor activation
- Ion channel transport
- Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
- Ligand-gated ion channel transport
- Transmission across Chemical Synapses
|
- Na+/Cl- dependent neurotransmitter transporters
- Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds
- SLC-mediated transmembrane transport
|
- Lorazepam
- Temazepam
- Clobazam
- Alprazolam
- Picrotoxin
- Chlordiazepoxide
- Adinazolam
- Clorazepate
- Midazolam
- Flurazepam
- Halazepam
- Diazepam
- Oxazepam
- Triazolam
- Clonazepam
- Estazolam
- Bromazepam
- Clotiazepam
- Fludiazepam
- Prazepam
- Quazepam
- Cinolazepam
- Nitrazepam
|
|
|
|
GABRR1 and SQSTM1 |
gamma-aminobutyric acid (GABA) A receptor, rho 1 |
sequestosome 1 |
- GABA receptor activation
- GABA A (rho) receptor activation
- Ion channel transport
- Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
- Ligand-gated ion channel transport
- Transmission across Chemical Synapses
|
- Signaling by Interleukins
- Signalling by NGF
- NF-kB is activated and signals survival
- p75NTR recruits signalling complexes
- Cell death signalling via NRAGE, NRIF and NADE
- NRIF signals cell death from the nucleus
- p75NTR signals via NF-kB
- Cytokine Signaling in Immune system
- Interleukin-1 signaling
- p75 NTR receptor-mediated signalling
|
- Lorazepam
- Temazepam
- Clobazam
- Alprazolam
- Picrotoxin
- Chlordiazepoxide
- Adinazolam
- Clorazepate
- Midazolam
- Flurazepam
- Halazepam
- Diazepam
- Oxazepam
- Triazolam
- Clonazepam
- Estazolam
- Bromazepam
- Clotiazepam
- Fludiazepam
- Prazepam
- Quazepam
- Cinolazepam
- Nitrazepam
|
|
|
|
GABRR1 and PRKG1 |
gamma-aminobutyric acid (GABA) A receptor, rho 1 |
protein kinase, cGMP-dependent, type I |
- GABA receptor activation
- GABA A (rho) receptor activation
- Ion channel transport
- Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
- Ligand-gated ion channel transport
- Transmission across Chemical Synapses
|
- Ca2+ pathway
- Signaling by Wnt
- beta-catenin independent WNT signaling
|
- Lorazepam
- Temazepam
- Clobazam
- Alprazolam
- Picrotoxin
- Chlordiazepoxide
- Adinazolam
- Clorazepate
- Midazolam
- Flurazepam
- Halazepam
- Diazepam
- Oxazepam
- Triazolam
- Clonazepam
- Estazolam
- Bromazepam
- Clotiazepam
- Fludiazepam
- Prazepam
- Quazepam
- Cinolazepam
- Nitrazepam
|
|
|
|
GABRR1 and MAPK1 |
gamma-aminobutyric acid (GABA) A receptor, rho 1 |
mitogen-activated protein kinase 1 |
- GABA receptor activation
- GABA A (rho) receptor activation
- Ion channel transport
- Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
- Ligand-gated ion channel transport
- Transmission across Chemical Synapses
|
- phospho-PLA2 pathway
- Ca-dependent events
- Signaling by FGFR in disease
- Cellular Senescence
- ERKs are inactivated
- CREB phosphorylation through the activation of Ras
- Signaling by EGFRvIII in Cancer
- Toll Like Receptor TLR1:TLR2 Cascade
- Toll Like Receptor 5 (TLR5) Cascade
- Gastrin-CREB signalling pathway via PKC and MAPK
- MyD88 dependent cascade initiated on endosome
- SOS-mediated signalling
- Fcgamma receptor (FCGR) dependent phagocytosis
- SHC-mediated signalling
- Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
- Regulation of actin dynamics for phagocytic cup formation
- TRIF-mediated TLR3/TLR4 signaling
- Senescence-Associated Secretory Phenotype (SASP)
- Signaling by VEGF
- Signalling to RAS
- Downstream signal transduction
- Toll Like Receptor 3 (TLR3) Cascade
- Interleukin-2 signaling
- Platelet activation, signaling and aggregation
- Frs2-mediated activation
- Transmission across Chemical Synapses
- Axon guidance
- IRS-mediated signalling
- L1CAM interactions
- Oncogene Induced Senescence
- VEGFA-VEGFR2 Pathway
- Activated TLR4 signalling
- VEGFR2 mediated cell proliferation
- GRB2 events in ERBB2 signaling
- RSK activation
- Activation of NMDA receptor upon glutamate binding and postsynaptic events
- TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
- MyD88:Mal cascade initiated on plasma membrane
- NCAM signaling for neurite out-growth
- Signalling to p38 via RIT and RIN
- RAF/MAP kinase cascade
- Innate Immune System
- Signaling by Insulin receptor
- ERKs are inactivated
- Signal transduction by L1
- Insulin receptor signalling cascade
- PLC beta mediated events
- IRS-related events
- Signaling by Ligand-Responsive EGFR Variants in Cancer
- SHC-related events
- G-protein mediated events
- Signaling by FGFR
- Thrombin signalling through proteinase activated receptors (PARs)
- ARMS-mediated activation
- Toll-Like Receptors Cascades
- Toll Like Receptor 10 (TLR10) Cascade
- Signal attenuation
- Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
- ERK/MAPK targets
- MAPK targets/ Nuclear events mediated by MAP kinases
- Signaling by GPCR
- Mitotic Prophase
- Golgi Cisternae Pericentriolar Stack Reorganization
- FCERI mediated MAPK activation
- Signaling by SCF-KIT
- SHC1 events in ERBB2 signaling
- DAP12 signaling
- Toll Like Receptor 9 (TLR9) Cascade
- ERK/MAPK targets
- Negative regulation of FGFR signaling
- Signaling by PDGF
- DAP12 interactions
- Opioid Signalling
- SHC-related events triggered by IGF1R
- GRB2 events in EGFR signaling
- Signaling by ERBB4
- Toll Like Receptor 2 (TLR2) Cascade
- Signaling by ERBB2
- Signaling by EGFR
- Signaling by Interleukins
- SHC1 events in ERBB4 signaling
- Toll Like Receptor 4 (TLR4) Cascade
- Fc epsilon receptor (FCERI) signaling
- Signaling by EGFR in Cancer
- Signaling by Leptin
- Growth hormone receptor signaling
- Signalling to ERKs
- Prolonged ERK activation events
- ERK activation
- Toll Like Receptor 7/8 (TLR7/8) Cascade
- IGF1R signaling cascade
- Recycling pathway of L1
- M Phase
- Toll Like Receptor TLR6:TLR2 Cascade
- IRS-related events triggered by IGF1R
- Activation of the AP-1 family of transcription factors
- MyD88 cascade initiated on plasma membrane
- ERK activation
- Downstream signaling of activated FGFR
- Advanced glycosylation endproduct receptor signaling
- Post NMDA receptor activation events
- Signalling by NGF
- SOS-mediated signalling
- MAP kinase activation in TLR cascade
- SHC-mediated signalling
- Cytokine Signaling in Immune system
- Cellular response to heat stress
- Regulation of HSF1-mediated heat shock response
- NGF signalling via TRKA from the plasma membrane
- MyD88-independent cascade
- Signaling by Overexpressed Wild-Type EGFR in Cancer
- Cell Cycle, Mitotic
- ERK2 activation
- SHC1 events in EGFR signaling
- FRS2-mediated cascade
- IRS-mediated signalling
- Oxidative Stress Induced Senescence
- ERK2 activation
- Nuclear Events (kinase and transcription factor activation)
|
- Lorazepam
- Temazepam
- Clobazam
- Alprazolam
- Picrotoxin
- Chlordiazepoxide
- Adinazolam
- Clorazepate
- Midazolam
- Flurazepam
- Halazepam
- Diazepam
- Oxazepam
- Triazolam
- Clonazepam
- Estazolam
- Bromazepam
- Clotiazepam
- Fludiazepam
- Prazepam
- Quazepam
- Cinolazepam
- Nitrazepam
|
- Isoproterenol
- Arsenic trioxide
- Olomoucine
- Phosphonothreonine
- Purvalanol
- SB220025
- N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE
- N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE
- (S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE
- (3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE
- 5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE
- (1aR,8S,13S,14S,15aR)-5,13,14-trihydroxy-3-methoxy-8-methyl-8,9,13,14,15,15a-hexahydro-6H-oxireno[k][2]benzoxacyclotetradecine-6,12(1aH)-dione
- [4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID
- 4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE
|
|
|
GABRR1 and PRKCA |
gamma-aminobutyric acid (GABA) A receptor, rho 1 |
protein kinase C, alpha |
- GABA receptor activation
- GABA A (rho) receptor activation
- Ion channel transport
- Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
- Ligand-gated ion channel transport
- Transmission across Chemical Synapses
|
- Ca-dependent events
- Signaling by GPCR
- CaM pathway
- Signaling by FGFR in disease
- Phospholipase C-mediated cascade
- Integration of energy metabolism
- Mitotic Prophase
- Signaling by Wnt
- Signaling by EGFRvIII in Cancer
- PLCG1 events in ERBB2 signaling
- Signaling by SCF-KIT
- DAP12 signaling
- Regulation of KIT signaling
- Gastrin-CREB signalling pathway via PKC and MAPK
- Response to elevated platelet cytosolic Ca2+
- G alpha (z) signalling events
- Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
- Signaling by PDGF
- Calmodulin induced events
- DAP12 interactions
- Regulation of mRNA stability by proteins that bind AU-rich elements
- Opioid Signalling
- Diseases associated with visual transduction
- EGFR interacts with phospholipase C-gamma
- Signaling by ERBB2
- Signaling by EGFR
- Syndecan interactions
- GPCR downstream signaling
- Signaling by VEGF
- Calmodulin induced events
- Downstream signal transduction
- WNT5A-dependent internalization of FZD4
- Signaling by EGFR in Cancer
- Platelet activation, signaling and aggregation
- PCP/CE pathway
- Transmission across Chemical Synapses
- Trafficking of GluR2-containing AMPA receptors
- Nuclear Envelope Breakdown
- HuR stabilizes mRNA
- DAG and IP3 signaling
- M Phase
- VEGFA-VEGFR2 Pathway
- CaM pathway
- Inactivation, recovery and regulation of the phototransduction cascade
- EGFR Transactivation by Gastrin
- VEGFR2 mediated cell proliferation
- Downstream signaling of activated FGFR
- The phototransduction cascade
- Disinhibition of SNARE formation
- Innate Immune System
- Signalling by NGF
- PLC beta mediated events
- Regulation of insulin secretion
- Depolymerisation of the Nuclear Lamina
- Signaling by Ligand-Responsive EGFR Variants in Cancer
- NGF signalling via TRKA from the plasma membrane
- G-protein mediated events
- Non-integrin membrane-ECM interactions
- Signaling by Overexpressed Wild-Type EGFR in Cancer
- Trafficking of AMPA receptors
- Cell Cycle, Mitotic
- Signaling by FGFR
- beta-catenin independent WNT signaling
- Acetylcholine regulates insulin secretion
- Visual phototransduction
- Ca2+ pathway
- PLC-gamma1 signalling
- Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity
|
- Lorazepam
- Temazepam
- Clobazam
- Alprazolam
- Picrotoxin
- Chlordiazepoxide
- Adinazolam
- Clorazepate
- Midazolam
- Flurazepam
- Halazepam
- Diazepam
- Oxazepam
- Triazolam
- Clonazepam
- Estazolam
- Bromazepam
- Clotiazepam
- Fludiazepam
- Prazepam
- Quazepam
- Cinolazepam
- Nitrazepam
|
- Phosphatidylserine
- Vitamin E
- Ingenol Mebutate
- Ellagic Acid
|
|
|
GABRR1 and PRKACA |
gamma-aminobutyric acid (GABA) A receptor, rho 1 |
protein kinase, cAMP-dependent, catalytic, alpha |
- GABA receptor activation
- GABA A (rho) receptor activation
- Ion channel transport
- Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
- Ligand-gated ion channel transport
- Transmission across Chemical Synapses
|
- Signaling by GPCR
- Ca-dependent events
- CaM pathway
- Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
- Metabolism of lipids and lipoproteins
- Integration of energy metabolism
- Hedgehog 'off' state
- Phospholipase C-mediated cascade
- Signaling by FGFR in disease
- Signaling by EGFRvIII in Cancer
- Regulation of PLK1 Activity at G2/M Transition
- PLCG1 events in ERBB2 signaling
- Gluconeogenesis
- Glucose metabolism
- DAP12 signaling
- Rap1 signalling
- Myoclonic epilepsy of Lafora
- Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis
- Glycogen storage diseases
- PKA-mediated phosphorylation of key metabolic factors
- Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
- Recruitment of mitotic centrosome proteins and complexes
- Glucagon signaling in metabolic regulation
- Signaling by PDGF
- Calmodulin induced events
- DAP12 interactions
- PKA-mediated phosphorylation of CREB
- Opioid Signalling
- PKA activation
- Factors involved in megakaryocyte development and platelet production
- Aquaporin-mediated transport
- CREB phosphorylation through the activation of Adenylate Cyclase
- EGFR interacts with phospholipase C-gamma
- Signaling by ERBB2
- PKA-mediated phosphorylation of CREB
- Signaling by EGFR
- Signaling by Interleukins
- Signaling by VEGF
- Downstream signal transduction
- Calmodulin induced events
- Signaling by EGFR in Cancer
- Metabolism of carbohydrates
- PKA activation
- Interleukin-3, 5 and GM-CSF signaling
- Mitotic G2-G2/M phases
- Transmission across Chemical Synapses
- Adaptive Immune System
- Organelle biogenesis and maintenance
- G2/M Transition
- VEGFA-VEGFR2 Pathway
- DAG and IP3 signaling
- CaM pathway
- Activation of NMDA receptor upon glutamate binding and postsynaptic events
- Loss of Nlp from mitotic centrosomes
- Downstream signaling of activated FGFR
- DARPP-32 events
- Post NMDA receptor activation events
- Innate Immune System
- PKA activation in glucagon signalling
- Signalling by NGF
- PLC beta mediated events
- Vasopressin regulates renal water homeostasis via Aquaporins
- Regulation of insulin secretion
- Cytokine Signaling in Immune system
- Assembly of the primary cilium
- Signaling by Ligand-Responsive EGFR Variants in Cancer
- Lipid digestion, mobilization, and transport
- NGF signalling via TRKA from the plasma membrane
- G-protein mediated events
- Signaling by Overexpressed Wild-Type EGFR in Cancer
- Anchoring of the basal body to the plasma membrane
- Cell Cycle, Mitotic
- Signaling by FGFR
- Loss of proteins required for interphase microtubule organization from the centrosome
- PLC-gamma1 signalling
- Signaling by Hedgehog
- Degradation of GLI1 by the proteasome
- Centrosome maturation
- GLI3 is processed to GLI3R by the proteasome
- Degradation of GLI2 by the proteasome
|
- Lorazepam
- Temazepam
- Clobazam
- Alprazolam
- Picrotoxin
- Chlordiazepoxide
- Adinazolam
- Clorazepate
- Midazolam
- Flurazepam
- Halazepam
- Diazepam
- Oxazepam
- Triazolam
- Clonazepam
- Estazolam
- Bromazepam
- Clotiazepam
- Fludiazepam
- Prazepam
- Quazepam
- Cinolazepam
- Nitrazepam
|
|
|
|
GATA1 and HDAC4 |
GATA binding protein 1 (globin transcription factor 1) |
histone deacetylase 4 |
- Factors involved in megakaryocyte development and platelet production
|
- Signaling by NOTCH1 HD Domain Mutants in Cancer
- Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
- Signaling by NOTCH
- Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
- NOTCH1 Intracellular Domain Regulates Transcription
- Signaling by NOTCH1
- Signaling by NOTCH1 PEST Domain Mutants in Cancer
- Signaling by NOTCH1 in Cancer
- Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
- Constitutive Signaling by NOTCH1 PEST Domain Mutants
- FBXW7 Mutants and NOTCH1 in Cancer
|
|
|
|
|
GATA1 and ZFPM2 |
GATA binding protein 1 (globin transcription factor 1) |
zinc finger protein, FOG family member 2 |
- Factors involved in megakaryocyte development and platelet production
|
- Factors involved in megakaryocyte development and platelet production
|
|
|
|
|
GATA3 and ZFPM2 |
GATA binding protein 3 |
zinc finger protein, FOG family member 2 |
- Factors involved in megakaryocyte development and platelet production
|
- Factors involved in megakaryocyte development and platelet production
|
|
|
|
|
GATA4 and ZFPM2 |
GATA binding protein 4 |
zinc finger protein, FOG family member 2 |
- Peptide hormone metabolism
- Generic Transcription Pathway
- Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)
- YAP1- and WWTR1 (TAZ)-stimulated gene expression
- Factors involved in megakaryocyte development and platelet production
- Incretin synthesis, secretion, and inactivation
|
- Factors involved in megakaryocyte development and platelet production
|
|
|
|
|
GBP2 and FXR1 |
guanylate binding protein 2, interferon-inducible |
fragile X mental retardation, autosomal homolog 1 |
- Interferon gamma signaling
- Interferon Signaling
- Cytokine Signaling in Immune system
- Interferon alpha/beta signaling
|
|
|
|
|
|
GBP3 and MAP4K4 |
guanylate binding protein 3 |
mitogen-activated protein kinase kinase kinase kinase 4 |
- Interferon gamma signaling
- Interferon Signaling
- Cytokine Signaling in Immune system
|
- Oxidative Stress Induced Senescence
- Cellular Senescence
|
|
|
|
|
GEM and TCF4 |
GTP binding protein overexpressed in skeletal muscle |
transcription factor 4 |
|
- CDO in myogenesis
- Myogenesis
|
|
|
|
|
GFAP and RORA |
glial fibrillary acidic protein |
RAR-related orphan receptor A |
- Nuclear signaling by ERBB4
- Signaling by ERBB4
|
- PPARA activates gene expression
- Fatty acid, triacylglycerol, and ketone body metabolism
- Metabolism of lipids and lipoproteins
- Generic Transcription Pathway
- Nuclear Receptor transcription pathway
- Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
- REV-ERBA represses gene expression
- BMAL1:CLOCK,NPAS2 activates circadian gene expression
- RORA activates circadian gene expression
|
|
|
|
|
GLP1R and NRGN |
glucagon-like peptide 1 receptor |
neurogranin (protein kinase C substrate, RC3) |
- Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
- Signaling by GPCR
- GPCR downstream signaling
- Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
- Integration of energy metabolism
- G alpha (s) signalling events
- Regulation of insulin secretion
- Glucagon-type ligand receptors
- Metabolic disorders of biological oxidation enzymes
- GPCR ligand binding
- Class B/2 (Secretin family receptors)
|
|
- Glucagon recombinant
- Exenatide
- Liraglutide
|
|
|
|
GLRA2 and BAG6 |
glycine receptor, alpha 2 |
BCL2-associated athanogene 6 |
- Ion channel transport
- Ligand-gated ion channel transport
|
|
- Glycine
- Lindane
- Picrotoxin
- Ethanol
|
|
|
|
GLUD1 and LSM1 |
glutamate dehydrogenase 1 |
LSM1, U6 small nuclear RNA associated |
- Amino acid synthesis and interconversion (transamination)
- Metabolism of amino acids and derivatives
|
- mRNA decay by 5' to 3' exoribonuclease
- Deadenylation-dependent mRNA decay
|
- L-Glutamic Acid
- NADH
- Hexachlorophene
- Nicotinamide-Adenine-Dinucleotide
- Adenosine-5\'-Diphosphate
- Guanosine-5\'-Triphosphate
|
|
|
|
GLUL and NFKB1 |
glutamate-ammonia ligase |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
- Astrocytic Glutamate-Glutamine Uptake And Metabolism
- Neurotransmitter uptake and Metabolism In Glial Cells
- Amino acid synthesis and interconversion (transamination)
- Metabolism of amino acids and derivatives
- Transmission across Chemical Synapses
|
- Signaling by the B Cell Receptor (BCR)
- NF-kB is activated and signals survival
- Downstream TCR signaling
- Toll Like Receptor 7/8 (TLR7/8) Cascade
- Cellular Senescence
- RIP-mediated NFkB activation via ZBP1
- Toll Like Receptor TLR6:TLR2 Cascade
- DEx/H-box helicases activate type I IFN and inflammatory cytokines production
- Activated TLR4 signalling
- Toll Like Receptor TLR1:TLR2 Cascade
- Downstream signaling events of B Cell Receptor (BCR)
- FCERI mediated NF-kB activation
- MyD88 cascade initiated on plasma membrane
- Toll Like Receptor 5 (TLR5) Cascade
- ZBP1(DAI) mediated induction of type I IFNs
- p75NTR signals via NF-kB
- Transcriptional regulation of white adipocyte differentiation
- MyD88 dependent cascade initiated on endosome
- TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
- MyD88:Mal cascade initiated on plasma membrane
- Toll Like Receptor 9 (TLR9) Cascade
- Innate Immune System
- Regulated proteolysis of p75NTR
- Signalling by NGF
- TRIF-mediated TLR3/TLR4 signaling
- Cytosolic sensors of pathogen-associated DNA
- Senescence-Associated Secretory Phenotype (SASP)
- Cytokine Signaling in Immune system
- p75 NTR receptor-mediated signalling
- MyD88-independent cascade
- Toll Like Receptor 2 (TLR2) Cascade
- RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
- Signaling by Interleukins
- TCR signaling
- Toll-Like Receptors Cascades
- Toll Like Receptor 10 (TLR10) Cascade
- Interleukin-1 processing
- Toll Like Receptor 3 (TLR3) Cascade
- Toll Like Receptor 4 (TLR4) Cascade
- Activation of NF-kappaB in B cells
- Fc epsilon receptor (FCERI) signaling
- TRAF6 mediated NF-kB activation
- Interleukin-1 signaling
- Adaptive Immune System
- TAK1 activates NFkB by phosphorylation and activation of IKKs complex
|
- L-Glutamine
- L-Glutamic Acid
|
- Thalidomide
- Pranlukast
- Triflusal
|
|
|